Related Experiment Video
Updated: Oct 24, 2026

Burn Injury-Induced Pain and Depression-Like Behavior in Mice
Published on: September 29, 2021
Ketamine in Modern Medicine: Current Evidence in Acute Pain, Opioid Use Disorder, and Depression
Eric S Schwenk1, Veena Graff1, Brian Malone1
1Department of Anesthesiology and Perioperative Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, 8290 Gibbon Building, 111 South 11th Street, Philadelphia, PA 19107, USA.
Abstract:
Ketamine has continued to be a valuable adjunct in perioperative care, supported by recent meta-analyses demonstrating opioid-sparing effects and improved analgesia, particularly in opioid-tolerant patients and painful surgeries. Its use should be targeted to patients most likely to benefit from its unique properties. Beyond acute pain, ketamine shows promise in patients with opioid use disorder by mitigating tolerance and withdrawal through N-methyl-d-aspartate receptor modulation and downstream neuroadaptive effects. Additionally, its established antidepressant properties position ketamine as a potentially advantageous agent for patients with coexisting pain and mood disorders, a population frequently encountered in perioperative practice.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Opioid Analgesics: Morphine and Other Natural Cogeners
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
